73 related articles for article (PubMed ID: 21495043)
1. Distortion product otoacoustic emission for the screening of cochlear damage in children treated with cisplatin.
Al-Noury K
Laryngoscope; 2011 May; 121(5):1081-4. PubMed ID: 21495043
[TBL] [Abstract][Full Text] [Related]
2. [Effects of Cisplatin on Auditory Function in Children with cancer. Otoacoustic Emission Evaluation].
Toral-Martiñón R; Poblano A; Collado-Corona MA; González R
Gac Med Mex; 2003; 139(6):529-34. PubMed ID: 14723047
[TBL] [Abstract][Full Text] [Related]
3. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.
Knight KR; Kraemer DF; Winter C; Neuwelt EA
J Clin Oncol; 2007 Apr; 25(10):1190-5. PubMed ID: 17401008
[TBL] [Abstract][Full Text] [Related]
4. Distortion product otoacoustic emissions test is useful in children undergoing cisplatin treatment.
Toral-Martiñón R; Shkurovich-Bialik P; Collado-Corona MA; Mora-Magaña I; Goldgrub-Listopad S; Shkurovich-Zaslavsky M
Arch Med Res; 2003; 34(3):205-8. PubMed ID: 14567400
[TBL] [Abstract][Full Text] [Related]
5. Distortion product otoacoustic emissions: an objective technique for the screening of hearing loss in children treated with platin derivatives.
Dhooge I; Dhooge C; Geukens S; De Clerck B; De Vel E; Vinck BM
Int J Audiol; 2006 Jun; 45(6):337-43. PubMed ID: 16777780
[TBL] [Abstract][Full Text] [Related]
6. Left-right asymmetry in hearing loss following cisplatin therapy in children--the left ear is slightly but significantly more affected.
Schmidt CM; Knief A; Lagosch AK; Deuster D; am Zehnhoff-Dinnesen A
Ear Hear; 2008 Dec; 29(6):830-7. PubMed ID: 18772725
[TBL] [Abstract][Full Text] [Related]
7. [Detection of ototoxic effect of cisplatin with otoacoustic emission in testicular cancer patients].
Biró K
Magy Onkol; 2009 Sep; 53(3):279-83. PubMed ID: 19793694
[TBL] [Abstract][Full Text] [Related]
8. [Detection of late ototoxic side effect of cisplatin by distortion otoacoustic emission (DPOAE)].
Biró K; Noszek L; Prekopp P; Nagyiványi K; Géczi L; Gaudi I; Bodrogi I
Magy Onkol; 2006; 50(4):329-35. PubMed ID: 17216007
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and risk factors of cisplatin-induced ototoxicity in testicular cancer patients detected by distortion product otoacoustic emission.
Biro K; Noszek L; Prekopp P; Nagyiványi K; Géczi L; Gaudi I; Bodrogi I
Oncology; 2006; 70(3):177-84. PubMed ID: 16757924
[TBL] [Abstract][Full Text] [Related]
10. [Distortion product otoacoustic emissions in newborns treated by ototoxic drugs].
Ruggieri-Marone M; Schochat E
Rev Laryngol Otol Rhinol (Bord); 2007; 128(1-2):41-6. PubMed ID: 17633664
[TBL] [Abstract][Full Text] [Related]
11. Changes to spontaneous otoacoustic emissions (SOAEs) due to cisplatin administration.
Kuroda T; Chida E; Kashiwamura M; Matsumura M; Fukuda S
Int J Audiol; 2008 Nov; 47(11):695-701. PubMed ID: 19031228
[TBL] [Abstract][Full Text] [Related]
12. Ototoxicity risk assessment combining distortion product otoacoustic emissions with a cisplatin dose model.
Dille MF; McMillan GP; Reavis KM; Jacobs P; Fausti SA; Konrad-Martin D
J Acoust Soc Am; 2010 Sep; 128(3):1163-74. PubMed ID: 20815453
[TBL] [Abstract][Full Text] [Related]
13. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.
Fetterman BL
Laryngoscope; 2001 Jun; 111(6):946-54. PubMed ID: 11404602
[TBL] [Abstract][Full Text] [Related]
14. The protective effect of Ginkgo biloba extract against experimental cisplatin ototoxicity: animal research using distortion product otoacoustic emissions.
Cakil B; Basar FS; Atmaca S; Cengel SK; Tekat A; Tanyeri Y
J Laryngol Otol; 2012 Nov; 126(11):1097-101. PubMed ID: 22975015
[TBL] [Abstract][Full Text] [Related]
15. Distortion-product otoacoustic emission: early detection in deferoxamine induced ototoxicity.
Delehaye E; Capobianco S; Bertetto IB; Meloni F
Auris Nasus Larynx; 2008 Jun; 35(2):198-202. PubMed ID: 17869044
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin ototoxicity in the Sprague Dawley rat evaluated by distortion product otoacoustic emissions.
Hatzopoulos S; Di Stefano M; Campbell KC; Falgione D; Ricci D; Rosignoli M; Finesso M; Albertin A; Previati M; Capitani S; Martini A
Audiology; 2001; 40(5):253-64. PubMed ID: 11688544
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
[TBL] [Abstract][Full Text] [Related]
18. Effect of high-dose cisplatin on auditory brainstem responses and otoacoustic emissions in laboratory animals.
Sockalingam R; Freeman S; Cherny TL; Sohmer H
Am J Otol; 2000 Jul; 21(4):521-7. PubMed ID: 10912698
[TBL] [Abstract][Full Text] [Related]
19. [Hearing evaluation in children during chemotherapy].
Lisowska G; Namysłowski G; Hajduk A; Polok A; Tomaszewska R; Misiołek M
Pol Merkur Lekarski; 2005 Sep; 19(111):340-2. PubMed ID: 16358863
[TBL] [Abstract][Full Text] [Related]
20. Light microscopy study of cisplatin-induced ototoxicity in rats.
de Freitas MR; de Castro Brito GA; de Carvalho JV; Gomes RM; Barreto Martins MJ; de Albuquerque Ribeiro R
J Laryngol Otol; 2009 Jun; 123(6):590-7. PubMed ID: 19144244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]